In particular, B cell depletion with the anti-CD20 antibody rituximab seems to work for RA patients resistant to standard disease-modifying antirheumatic drugs (DMARDs) and tumor necrosis factor ...

However, she reckons it will still trail Roche's first-to-market anti-CD20 drug Ocrevus (ocrelizumab), even though that drug needs to be administered by intravenous infusion. While it requires a ...

Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Atara ...

Biogen BIIB reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.44, which beat the Zacks Consensus Estimate of $3.42. Earnings rose 17% year over year on a reported basis, boosted by ...

Investigation Details On January 16, 2025, Atara announced that it had received "a Complete Response Letter (CRL) from the ...

AMPLIFY is testing BTK inhibitor Calquence (acalabrutinib) in combination with AbbVie/Roche's BCL-2 inhibitor Venclexta (venetoclax) – with or without Roche's anti-CD20 drug Gazyva (obinutuzumab ...

LOS ANGELES, CA / ACCESS Newswire / February 8, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...

The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.

Roche’s Gazyva/Gazyvaro (obinutuzumab) has demonstrated superiority over standard therapy in patients with active lupus ...

The thing that is especially concerning about antiarrhythmic drugs is their unique toxicity, which often makes them difficult and relatively risky to administer and to take. There are two general ...

The Customs Department and the Bermuda Police Service [BPS] recently conducted joint training to “strengthen border security and combat the growing threat of drug and weapon smuggling.” ...

Obinutuzumab is a type II anti-CD20 antibody that results in greater B-cell depletion than rituximab ... Efficacy analyses were done in a modified intention-to-treat population consisting of all ...